A two-minute talk could save lives: testing a nudge for bowel cancer screening

NCT ID NCT07721740

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This pilot study tests whether a short, supportive conversation—called patient navigation—can encourage men aged 65 and older who have missed their bowel cancer screening to complete it. The conversation happens during a routine abdominal aortic aneurysm (AAA) screening appointment and lasts only 1.5 to 2 minutes. Researchers will measure how many men complete a bowel screening test within three months and whether the approach is practical and acceptable to both patients and staff.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient navigation conversation
What this could lead to
If effective, this simple conversation could be a low-cost way to increase bowel cancer screening rates in older men who have missed their screening.
What could go wrong
This is a small pilot study without a comparison group, so it cannot prove the conversation itself causes higher screening uptake. Results may not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 4,190 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men aged 65 years and above * Attending an AAA screening appointment * Have not completed their most recent bowel screening * Agree to discuss bowel screening further Exclusion Criteria: * Men aged \<65years * Those who do not attend their AAA screening appointment * Have completed their most recent bowel screening * Do not agree to discuss bowel screening further * Those who received a positive AAA result in their appointment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bowel cancer screening are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospitals of Leicester NHS Trust

    Leicester, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.